PPT-Arg -ADNI ADNI annual meeting

Author : tawny-fly | Published Date : 2018-03-06

AAIC 2017 Presenter Dr Patricio Chrem On Behalf of Dr Prof Ricardo Allegri PI Dr Gustavo Sevlever July 14 th 2017 Arg ADNI Patients Flowchart Patients Screened

Presentation Embed Code

Download Presentation

Download Presentation The PPT/PDF document "Arg -ADNI ADNI annual meeting" is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.

Arg -ADNI ADNI annual meeting: Transcript

AAIC 2017 Presenter Dr Patricio Chrem On Behalf of Dr Prof Ricardo Allegri PI Dr Gustavo Sevlever July 14 th 2017 Arg ADNI Patients Flowchart Patients Screened at FLENI. Leslie M Shaw & John Q . Trojanowski. Magdalena Korecka. Michal Figurski. Teresa . Waligorska. Magdalena Brylska. Leona Fields. Nirali. Shah. Biomarker Core Aims for ADNI 3. Continue to collect, store, curate and track all . . Arg. -ADNI. Gustavo E. Sevlever . , Ricardo . F. . Allegri (. *. ), . Silvia Vázquez, Deborah R. . Gustafson. , . Salvador M. Guinjoan, . and Arg-ADNI group.. Memory and Aging Center. Institute for Neurological Research . Andy Saykin. WW-ADNI Meeting. London, UK. July 14, 2017. asaykin@iupui.edu. Overview and 2017 Updates. ADNI-3 sample collection (banked at NCRAD). Longitudinal DNA & RNA (12 new, 79 continuing). Changes in ADNI-3 include PBMC and RBC collection. Update. Veronika. . Logovinsky. , MD, PhD. . 2017 . Chairperson . WW ADNI Meeting. July . 14, 2017. PPSB: Leadership. Chair. N/A. Chair-elect. Veronika . Logovinsky. , Eisai. FNIH. Michael Biarnes, Scientific Project Manager* . Initiative . December, 2010. NEED FOR VALIDATED BIOMARKERS FOR AD TRIALS. Biomarkers useful in Phase 2 to make decisions about Phase 3 (e.g. doses). Biomarkers useful in Phase 3. Provide additional evidence to support primary outcome findings. Update. James Hendrix. , PhD. 2018 Chairperson . WW ADNI Meeting. July 20, 2018. PPSB: Leadership. Chair. James Hendrix, Alzheimer’s Association . Chair-elect. Aparna . Vasanthakumar. , AbbVie . FNIH. Leslie M Shaw and John Q Trojanowski. WW ADNI meeting. Chicago, July 20, 2018. CSF. Ser. + . Pla. TOTAL. ADNI 1 Primary . Biofluids. Collected. 1118. 9756. 10874. ADNI . 1 Aliquots in Bank. 24934. Boston, MA 4/24/2017 . Leslie M Shaw. John Q Trojanowski. New biomarkers in NIA/ADNI/RARC-approved studies . Biomarker. Fluid. #. ADNI study. Investigator. NFL & Tau . diag. /prognosis. Plasma. 3,000+. Mayo. . Cliff Jack. Bret Borowski . Matt Bernstein. Arvin Forghanian-Arani . Jeff Gunter. Dave Jones . Kejal Kantarci. Rob Reid . Denise Reyes . Matt Senjem. Kaely Thostenson. Prashanthi Vemuri . Chad Ward . WW-ADNI Meeting, Washington DC. July 17, 2015. Andy Saykin, . Indiana University. asaykin@iupui.edu. For the Genetics Core/Working Groups. Original ADNI-2 Specific Aims. Progress Report & Impact. Silvia Vázquez, Deborah R. . Gustafson. , . Salvador M. Guinjoan, . Ricardo F. Allegri. and . Arg. -ADNI . group. .. Memory and Aging Center. Institute for Neurological Research . (FLENI. ) . Buenos Aires, Argentina. Bret Borowski . Matt Bernstein. Arvin Forghanian-Arani . Jeff Gunter. Dave Jones . Kejal Kantarci. Rob Reid . Denise Reyes . Matt Senjem. Kaely Thostenson. Prashanthi Vemuri . Chad Ward . Funded MRI Investigators. Bret Borowski . Matt Bernstein. Arvin Forghanian-Arani . Jeff Gunter. Dave Jones . Kejal Kantarci. Rob Reid . Denise Reyes . Matt Senjem. Kaely Thostenson. Prashanthi Vemuri . Chad Ward . Funded MRI Investigators. Cliff Jack. Bret Borowski . Matt Bernstein. Arvin Forghanian-Arani . Jeff Gunter. Dave Jones . Kejal Kantarci. Rob Reid . Denise Reyes . Matt Senjem. Kaely Thostenson. Prashanthi Vemuri . Chad Ward .

Download Document

Here is the link to download the presentation.
"Arg -ADNI ADNI annual meeting"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.